Casdin Capital Portfolio

Casdin Capital 13F filer (CIK 0001534261).

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2018 · 32 positions · Total reported value $590.57M · Top-10 concentration 65.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 26.1% · 6 new · 3 cut · 3 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +47.2% · vs SPY +32.4% · Prev Value $1.32B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2018 13F filing, Casdin Capital disclosed 32 equity positions with a combined reported value of $590.57M. The filing implies a focused portfolio: its ten largest positions account for 65.1% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2018 were FMI ($93.64M), SAGE ($39.13M), MYOK ($38.73M). By sector, the heaviest allocations are Health Care 36.2%, Industrials 4.9%. Versus the prior quarter, allocation shifted toward Health Care (+5.2pp), Industrials (+1.0pp) and away from Consumer Discretionary (-0.8pp), Other (-5.4pp).

Versus the prior quarter, Casdin Capital opened 6 new positions, trimmed 3 and fully exited 3, a turnover rate of 26.1% of positions. The portfolio's overlap with the prior quarter was 80% of names.

The largest new positions opened in Q2 2018 were MGTA ($27.48M), BLFS ($11.41M), NTGN ($4.26M).

Of the 3 positions fully exited versus the prior quarter, the largest were IBB ($10.14M), CELG ($3.57M), ADVM ($1.74M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2018)

  • MGTA MAGENTA THERAPEUTICS INC · $27.48M
  • BLFS BIOLIFE SOLUTIONS INC · $11.41M
  • NTGN NEON THERAPEUTICS INC · $4.26M
  • CDNA CAREDX INC · $2.45M

Fully Exited (vs previous quarter)

  • IBB ISHARES TR · prev qtr: $10.14M
  • CELG CELGENE CORP · prev qtr: $3.57M
  • ADVM ADVERUM BIOTECHNOLOGIES INC · prev qtr: $1.74M

Insider Transactions (Form 4)

Latest Casdin Capital buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Casdin Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 43 US equity positions with a combined value of $2.00B. HoldingsHub carries 43 quarters of its filings (Q4 2015–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-110894 (status: Approved), registered 2017-07-31
  • Regulatory AUM (Form ADV): $2.87B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds

Portfolio Structure

  • 43 positions · $2.00B reported value (Q2 2026)
  • Top 10 holdings = 77.4% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 24.2%
  • Average position size: $46.46M

Sector Tilt

  • Health Care 94.2%
  • Industrials 5.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 9 added, 3 reduced, 3 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 36.2%
Other 56.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 685.00K $93.64M 15.86%
15.86%
Add
2 250.00K $39.13M 6.63%
6.63%
Hold
3 780.00K $38.73M 6.56%
6.56%
Add
4 463.00K $38.32M 6.49%
6.49%
Hold
5 200.00K $31.39M 5.32%
5.32%
Add
6 364.78K $30.73M 5.20%
5.20%
Hold
7 2.60M $29.48M 4.99%
4.99%
Hold
8 2.02M $29.16M 4.94%
4.94%
Hold
9 2.04M $27.48M 4.65%
4.65%
New
10 270.00K $26.59M 4.50%
4.50%
Add
11 1.14M $22.18M 3.75%
3.75%
Hold
12 3.40M $21.69M 3.67%
3.67%
Reduce
13 71.50K $19.97M 3.38%
3.38%
Hold
14 1.40M $19.88M 3.37%
3.37%
Hold
15 450.00K $17.20M 2.91%
2.91%
Hold
16 220.00K $12.93M 2.19%
2.19%
Add
17 550.00K $11.58M 1.96%
1.96%
Reduce
18 1.00M $11.41M 1.93%
1.93%
New
19 70.00K $10.76M 1.82%
1.82%
Hold
20 640.00K $10.54M 1.78%
1.78%
Add
21 220.00K $10.00M 1.69%
1.69%
Add
22 178.33K $6.39M 1.08%
1.08%
Add
23 65.00K $5.21M 0.88%
0.88%
Hold
24 207.50K $4.74M 0.80%
0.80%
Hold
25 338.35K $4.26M 0.72%
0.72%
New
26 20.00K $3.47M 0.59%
0.59%
Reduce
27 135.00K $3.14M 0.53%
0.53%
Hold
28 375.00K $2.87M 0.49%
0.49%
Reduce
29 200.00K $2.45M 0.41%
0.41%
New
30 115.00K $2.35M 0.40%
0.40%
Add
31 50.00K $2.26M 0.38%
0.38%
Reduce
32 10.00K $635.00K 0.11%
0.11%
Reduce

FAQ

What did Casdin Capital buy in 2018-Q2?

In its 2018-Q2 13F filing, Casdin Capital reported 32 equity positions worth $590.57M in aggregate; its largest disclosed positions were FMI ($93.64M), SAGE ($39.13M), MYOK ($38.73M).

How large is Casdin Capital's portfolio?

Casdin Capital reported $590.57M of long equity holdings across 32 positions as of 2018-Q2. Top-10 holdings account for 65.1% of reported value.

What is Casdin Capital's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/casdin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →